Skip to main content

Table 2 Treatment-Related Preoperative Grade 3 or 4 Adverse Events

From: Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

Adverse Event

Grade 3

Grade 4

Hematologic

 Leukopenia

6 (15.0 %)

2 (5.0 %)

 Neutropenia

3 (7.5 %)

2 (5.0 %)

 Anemia requiring blood transfusion

2 (5.0 %)

 

 Febrile neutropenia

1 (2.5 %)

2 (5.0 %)

 Thrombocytopenia

 

1 (2.5 %)

Gastrointestinal

 Dysphagia, esophagitis, odynophagia

7 (17.5 %)

1 (2.5 %)

 Anorexia

7 (17.5 %)

 

 Dehydration

7 (17.5 %)

 

 Nausea

6 (15.0 %)

 

 Diarrhea

4 (10.0 %)

 

 Vomiting

4 (10.0 %)

 

 Abdominal pain or cramping

2 (5.0 %)

 

Systemic

 Fatigue

3 (7.5 %)

 

 Hypotension

3 (7.5 %)

1 (2.5 %)

 Hyperbilirubinemia

1 (2.5 %)

 

 Creatinine Elevation

1 (2.5 %)

 

 Chest pain (non-cardiac)

1 (2.5 %)

 

 Supraventricular arrhythmia

1 (2.5 %)

 

 Syncope

1 (2.5 %)

 

 Thrombosis/embolism

 

1 (2.5 %)